Dividend Details

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2081.001.3 (+0.06 %)
PREV CLOSE ( ) 2079.70
OPEN PRICE ( ) 2063.45
BID PRICE (QTY) 2079.45 (1)
OFFER PRICE (QTY) 2083.05 (2)
VOLUME 1637
TODAY'S LOW / HIGH ( )2063.45 2103.50
52 WK LOW / HIGH ( )1240.55 2355.05
NSE2081.002.15 (+0.1 %)
PREV CLOSE( ) 2078.85
OPEN PRICE ( ) 2078.85
BID PRICE (QTY) 2081.00 (75)
OFFER PRICE (QTY) 2082.55 (8)
VOLUME 30163
TODAY'S LOW / HIGH( ) 2069.15 2107.95
52 WK LOW / HIGH ( )1246.75 2353.95

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.